1. Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study. (8th October 2020) Authors: Kinoshita, Tomohiro; Hatake, Kiyohiko; Yamamoto, Kazuhito; Higuchi, Yusuke; Murakami, Satsuki; Terui, Yasuhito; Yokoyama, Masahiro; Maruyama, Dai; Makita, Shinichi; Hida, Yukari; Saito, Tomohisa; Tobinai, Kensei Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 1(2021) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗